These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32852729)

  • 1. Decreased serum myonectin concentrations in diabetic nephropathy patients.
    Zhang J; Hu W; Lin P; Wang R
    Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum Adropin Concentrations with Diabetic Nephropathy.
    Hu W; Chen L
    Mediators Inflamm; 2016; 2016():6038261. PubMed ID: 27546995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of serum meteorin-like concentrations with diabetic nephropathy.
    Wang R; Hu D; Zhao X; Hu W
    Diabetes Res Clin Pract; 2020 Nov; 169():108443. PubMed ID: 32946852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum preptin concentrations in patients with diabetic nephropathy.
    Wang R; Xue A; Zheng W; Wang L; Yan F; Hu W; Lin J; He L
    J Investig Med; 2019 Oct; 67(7):1048-1052. PubMed ID: 31182468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum and aqueous humor myonectin concentrations with diabetic retinopathy.
    Sun H; Li Z; Hu W; Ma W
    Sci Rep; 2021 Mar; 11(1):7215. PubMed ID: 33785845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation of serum musclin with diabetic nephropathy.
    Zhang J; Shi J; Cheng Z; Hu W
    Cytokine; 2023 Jul; 167():156211. PubMed ID: 37137178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy.
    Emara AM; El Bendary AS; Ahmed LM; Okda HI
    BMC Nephrol; 2024 Jul; 25(1):231. PubMed ID: 39030467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Serum Myonectin Levels in Obesity and Type 2 Diabetes Mellitus.
    Li Z; Yang YL; Zhu YJ; Li CG; Tang YZ; Ni CL; Chen LM; Niu WY
    Exp Clin Endocrinol Diabetes; 2021 Jul; 129(7):528-534. PubMed ID: 31340393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
    Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
    Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum pentraxin 3 concentrations with diabetic nephropathy.
    Wang R; Zhang J; Hu W
    J Investig Med; 2016 Aug; 64(6):1124-7. PubMed ID: 27233528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of serum myonectin concentrations with the presence and severity of obstructive sleep apnoea syndrome.
    Zou H; Yang W; Liu Y
    Ann Clin Biochem; 2021 Mar; 58(2):117-122. PubMed ID: 33231092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients.
    Chang YH; Lin KD; Wang CL; Hsieh MC; Hsiao PJ; Shin SJ
    Diabetes Metab Res Rev; 2008; 24(8):629-34. PubMed ID: 18973209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced serum CTRP12 levels in type 2 diabetes are associated with renal dysfunction.
    Du J; Xu J; Wang X; Liu Y; Zhao X; Zhang H
    Int Urol Nephrol; 2020 Dec; 52(12):2321-2327. PubMed ID: 32734505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocan and albuminuria in type 2 diabetes mellitus.
    Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
    Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
    Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myonectin Predicts the Development of Type 2 Diabetes.
    Li K; Liao X; Wang K; Mi Q; Zhang T; Jia Y; Xu X; Luo X; Zhang C; Liu H; Zhen H; Li L; Yang G
    J Clin Endocrinol Metab; 2018 Jan; 103(1):139-147. PubMed ID: 29161407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.